repoitin 5000 injection - Recombinant Human Erythropoietin Alfa (5000IU) medicine

Epofit 5000IU Injection: Complete Guide to Uses, Dosage, and Safety

No reviews yet
🏭 Serum Institute Of India Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Sep 23, 2026
📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: High for approved indications.
Reviewed by
SaathiMed Expert Panel | Sep 23, 2026

When to Call Your Doctor IMMEDIATELY

  • Severe headache with blurred vision or confusion
  • Chest pain, shortness of breath, or rapid heartbeat
  • Sudden weakness or numbness on one side of the body
  • Swelling, pain, or redness in an arm or leg
  • Seizures or loss of consciousness
  • Signs of severe allergic reaction: rash, itching, swelling of face, lips, or throat, difficulty breathing
  • Unusual fatigue or paleness despite treatment
  • Decreased urine output or swelling in the legs

If experiencing severe symptoms, call emergency services immediately.

What is repoitin 5000 injection used for?

This medicine is a recombinant human erythropoietin alfa injection used to treat anaemia in chronic kidney disease, chemotherapy, and HIV patients. It stimulates red blood cell production and is given by injection under medical supervision.

  • Generic Name: Recombinant Human Erythropoietin Alfa (5000IU)
  • Manufacturer: Serum Institute Of India Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 repoitin 5000 injection के बारे में (Hindi Summary)

उपयोग: यह दवा रीकॉम्बिनेंट ह्यूमन एरिथ्रोपोइटिन अल्फा का इंजेक्शन है, जिसका उपयोग खून की कमी (एनीमिया) के इलाज के लिए किया जाता है। यह मुख्य रूप से क्रोनिक किडनी रोग, कीमोथेरेपी से होने वाले एनीमिया, और एचआईवी रोगियों में जिडोवुडीन दवा के कारण होने वाले एनीमिया में दिया जाता है। यह शरीर में लाल रक्त कोशिकाओं के उत्पादन को बढ़ाता है, जिससे थकान, कमजोरी और सांस फूलने जैसे लक्षणों में सुधार होता है। यह दवा डॉक्टर की देखरेख में इंजेक्शन के रूप में दी जाती है और इसे स्वयं नहीं लगाना चाहिए।

साइड इफेक्ट्स: इस दवा के सामान्य दुष्प्रभावों में उच्च रक्तचाप, सिरदर्द, जोड़ों और मांसपेशियों में दर्द, मतली, उल्टी, दस्त, बुखार, थकान और इंजेक्शन लगाने की जगह पर दर्द या सूजन शामिल हैं। गंभीर दुष्प्रभावों में तेज रक्तचाप, दौरे, रक्त के थक्के बनना, दिल का दौरा, स्ट्रोक और एलर्जी प्रतिक्रिया हो सकती है। यदि आपको सीने में दर्द, सांस लेने में कठिनाई, गंभीर सिरदर्द, या चेहरे पर सूजन हो, तो तुरंत डॉक्टर से संपर्क करें।

सुरक्षा सलाह: यह दवा केवल डॉक्टर की देखरेख में ही दी जानी चाहिए। बिना प्रशिक्षण के स्वयं इंजेक्शन न लगाएं। अपने रक्तचाप, हीमोग्लोबिन और आयरन के स्तर की नियमित जांच कराते रहें। डॉक्टर की सलाह के बिना दवा की खुराक न बढ़ाएं या कम न करें। यदि आपको उच्च रक्तचाप, दौरे, रक्त के थक्के, हृदय रोग या कैंसर की समस्या है, तो अपने डॉक्टर को बताएं। इस दवा के साथ शराब का सेवन न करें। दवा को 2°C से 8°C के बीच रेफ्रिजरेटर में रखें, जमने न दें।

💡 Did You Know? Over 80% of the antiretroviral drugs used globally to combat AIDS are supplied by Indian pharmaceutical companies.

💊 repoitin 5000 injection Uses & Benefits

[{"condition":"Anaemia of chronic kidney disease","description":"This medicine is used to treat anaemia in patients with chronic kidney disease, including those on dialysis and those not yet on dialysis, to reduce the need for blood transfusions and improve quality of life.","evidence":"Well-established"},{"condition":"Chemotherapy-induced anaemia","description":"This medicine is used to treat anaemia in cancer patients receiving myelosuppressive chemotherapy, with the goal of reducing transfusion requirements and improving anaemia-related symptoms.","evidence":"Well-established"},{"condition":"Anaemia in HIV-infected patients on zidovudine","description":"This medicine is used to treat anaemia associated with zidovudine therapy in HIV-positive patients, helping to maintain red blood cell counts and reduce transfusions.","evidence":"Well-established"},{"condition":"Anaemia in patients undergoing surgery","description":"This medicine may be used to reduce the need for allogeneic blood transfusions in patients undergoing elective surgery with significant expected blood loss, as part of a patient blood management programme.","evidence":"Established"},{"condition":"Anaemia of prematurity","description":"This medicine may be used in premature infants to prevent or treat anaemia of prematurity, although its use is controversial and requires specialist neonatal care.","evidence":"Limited"}]

Off-label uses: [{"condition":"Myelodysplastic syndromes","description":"Sometimes used off-label to treat anaemia in patients with low-risk myelodysplastic syndromes, but response rates are variable and it is not approved for this indication in all regions.","evidence":"Limited"},{"condition":"Anaemia in critically ill patients","description":"Occasionally used off-label in critically ill patients to reduce transfusion requirements, but evidence is conflicting and risks may outweigh benefits.","evidence":"Limited"}]

Primary treatment for: Anaemia associated with chronic kidney disease

Also treats: Chemotherapy-induced anaemia, Anaemia in HIV patients on zidovudine, Anaemia in patients undergoing surgery

📋 Drug Information

Generic Name(s)Recombinant Human Erythropoietin Alfa (5000IU)
Brand Namerepoitin 5000 injection
ManufacturerSerum Institute Of India Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassBLOOD RELATED
Action ClassErythropoiesis-stimulating agent (ESA)
Route of AdministrationParenteral (intravenous or subcutaneous)
StorageStore in a refrigerator at 2°C to 8°C. Do not freeze. Keep the vial in the original carton to protect from light. Do not shake. Once removed from the refrigerator, allow the vial to reach room temperature before injection. Do not use if the solution is discoloured or contains particulate matter.
Shelf LifeThe shelf life is typically 24 months from the date of manufacture when stored under recommended conditions. Refer to the product label for the exact expiry date.
WHO GuidelineThe World Health Organization includes erythropoiesis-stimulating agents in its Model List of Essential Medicines for the treatment of anaemia in chronic kidney disease and cancer. However, specific recommendations should be based on current clinical guidelines.
ICMR GuidelineThe Indian Council of Medical Research has not published specific guidelines for this medicine. Consult local clinical guidelines for anaemia management.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Always check blood pressure before administering this medicine; uncontrolled hypertension is a contraindication.
2
Ensure adequate iron stores before starting therapy; iron deficiency will reduce efficacy.
3
Monitor haemoglobin levels every 2 to 4 weeks and adjust the dose to maintain target levels.
4
Use the lowest effective dose to reduce the risk of cardiovascular events.
5
Rotate injection sites to prevent lipodystrophy and skin reactions.
6
Educate patients on recognizing signs of thromboembolism and when to seek help.
7
Avoid targeting haemoglobin above 12 g/dL, especially in cancer patients.
8
Store the medicine in the refrigerator and do not freeze; protect from light.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

Chronic fatigue and weakness
This medicine is commonly prescribed for anaemia-related fatigue.
Likely Use
Shortness of breath
May be used if due to anaemia.
Likely Use
Pale skin
A sign of anaemia that this medicine treats.
Likely Use
Fever
This medicine is not a primary fever reducer.
Not Primary
Joint pain
This medicine is not a pain reliever; it may cause joint pain as a side effect.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionFollowing subcutaneous administration, recombinant human erythropoietin alfa is absorbed slowly and reaches peak plasma levels in approximately 5 to 24 hours. The bioavailability after subcutaneous injection is approximately 20% to 30% of that achieved with intravenous administration. After intravenous injection, the medicine is delivered directly into the bloodstream with 100% bioavailability.
DistributionThe volume of distribution of recombinant human erythropoietin alfa is approximately 0.05 to 0.1 L/kg, which is close to the plasma volume. It does not distribute extensively into tissues. The medicine is largely confined to the vascular space.
Protein BindingNot established from the available information.
MetabolismThe metabolism of recombinant human erythropoietin alfa is not fully characterised. It is believed to be metabolised in the body via general protein catabolism, similar to endogenous erythropoietin, primarily in the liver and possibly in the bone marrow. No specific cytochrome P450 enzymes are involved.
Half-LifeThe elimination half-life of recombinant human erythropoietin alfa varies with route of administration. After intravenous administration, the half-life is approximately 4 to 13 hours in patients with chronic kidney disease. After subcutaneous administration, the half-life is longer, approximately 24 hours, due to slow absorption.
ExcretionThe exact route of excretion is not fully established. It is thought that the medicine is cleared from the circulation by receptor-mediated endocytosis and subsequent degradation in the liver and bone marrow. Only a small amount is excreted unchanged in the urine.
BioavailabilityAfter subcutaneous administration, the bioavailability of recombinant human erythropoietin alfa is approximately 20% to 30%. After intravenous administration, bioavailability is 100%.
Onset of ActionThe onset of action is gradual. An increase in reticulocyte count can be observed within 3 to 7 days after starting therapy. A significant rise in haemoglobin typically occurs within 2 to 6 weeks, depending on the dose and patient factors.
Peak Plasma TimeAfter subcutaneous administration, peak plasma concentrations are reached in approximately 5 to 24 hours. After intravenous administration, peak concentrations occur immediately at the end of injection.
Duration of ActionThe effect on erythropoiesis lasts for several days to weeks after a dose, as the stimulated red blood cell precursors continue to mature. The haemoglobin level may continue to rise for several weeks after starting therapy, and it may take several weeks to return to baseline after stopping the medicine.

How It Works

Recombinant human erythropoietin alfa is a glycoprotein that binds to and activates erythropoietin receptors on the surface of erythroid progenitor cells in the bone marrow. This binding triggers intracellular signalling pathways, primarily the JAK2/STAT5 pathway, which promote cell survival, proliferation, and differentiation into mature red blood cells. It also stimulates the release of reticulocytes from the bone marrow into the bloodstream. By increasing the number of red blood cells, this medicine improves oxygen-carrying capacity and reduces anaemia-related symptoms. The effect is dependent on adequate iron stores, as iron is essential for haemoglobin synthesis.

Mechanism Steps

1
Binding to erythropoietin receptor: This medicine binds specifically to erythropoietin receptors on the surface of erythroid progenitor cells in the bone marrow.
2
Receptor dimerization and activation: Binding causes the receptor to dimerize and activate intracellular signalling, primarily through the JAK2 kinase pathway.
3
Signal transduction: Activated JAK2 phosphorylates STAT5, which translocates to the nucleus and promotes transcription of genes involved in cell survival and proliferation.
4
Proliferation and differentiation: Erythroid progenitor cells proliferate and differentiate into proerythroblasts and then into mature red blood cells.
5
Increased red blood cell production: The bone marrow releases more reticulocytes and red blood cells into the circulation, raising haemoglobin and haematocrit levels.

💡 How to Take repoitin 5000 injection

Strength: 5000 IU injection (pre-filled syringe or vial)

1This medicine is given by injection under the skin (subcutaneous) or into a vein (intravenous) by a healthcare professional.
2If you are trained to self-inject, follow your doctor's instructions carefully.
3Wash your hands thoroughly before preparing the injection.
4Check the vial for particles or discolouration; do not use if present.
5Use a new needle and syringe for each injection.
6Rotate injection sites to prevent skin irritation.
7Do not shake the vial; swirl gently if needed.
8Dispose of used needles and syringes in a sharps container.
9Follow your doctor's schedule for blood tests and monitoring.

Dosage Information

Adult DosageThe dose of this medicine must be individualized by a qualified clinician based on the indication, patient's age, weight, renal and hepatic function, and response to therapy. For anaemia of chronic kidney disease, a typical starting dose is 50 to 100 IU/kg three times per week intravenously or subcutaneously. For chemotherapy-induced anaemia, a typical starting dose is 150 IU/kg three times per week subcutaneously or 40,000 IU once weekly. The dose is adjusted to maintain haemoglobin within the target range, usually 10 to 12 g/dL. Do not exceed the recommended dose. Regular monitoring of haemoglobin, blood pressure, and iron status is essential.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatrician.
Elderly DosageElderly patients may be more sensitive to the effects of this medicine, particularly regarding blood pressure and cardiovascular risks. Dose selection should be cautious, and monitoring should be more frequent. No specific dose adjustment is recommended solely based on age, but individualization is essential.
Renal ImpairmentIn patients with chronic kidney disease, the dose should be individualized based on the severity of anaemia and response. Close monitoring of renal function and blood pressure is required. Dose reduction may be necessary in patients with severe renal impairment.
Hepatic ImpairmentThe safety and efficacy of this medicine in patients with hepatic impairment have not been established. Use with caution and monitor liver function tests.
Maximum Daily DoseThe maximum recommended dose varies by indication and is determined by the clinician. Do not exceed the prescribed dose. In general, doses above 300 IU/kg per week are not recommended.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

With food
No specific food restrictions
This medicine is given by injection and does not interact with food directly.
Alcohol
Avoid
Alcohol may worsen hypertension and increase cardiovascular risk.
High-potassium foods
Consume in moderation
This medicine may increase potassium levels, especially in kidney disease.

⏰ What to Do If You Miss a Dose

📌 Less than half the dosing interval has passed
→ Take the missed dose as soon as you remember.
💡 Continue with the regular schedule.
📌 More than half the dosing interval has passed
→ Skip the missed dose.
💡 Do not double dose to catch up.

⚠️ Side Effects of repoitin 5000 injection

✅ Common Side Effects

High blood pressure (Common (10-20%))
Monitor your blood pressure regularly. If it remains elevated, consult your doctor; dose adjustment or additional blood pressure medication may be needed.
Headache (Common (5-15%))
Usually resolves on its own. If persistent or severe, consult your doctor.
Joint pain (Common (5-10%))
Over-the-counter pain relievers may help, but consult your doctor before taking any new medicine.
Muscle pain (Common (5-10%))
Rest and gentle stretching may help. Consult your doctor if pain is severe or persistent.
Nausea (Common (5-10%))
Take small, frequent meals. If nausea is severe or accompanied by vomiting, contact your doctor.
Injection site reaction (Common (10-20%))
Apply a cold compress. Rotate injection sites. If redness, swelling, or pain worsens, consult your doctor.

🚨 Serious Side Effects

Hypertensive crisis (Uncommon (0.1-1%))
Seek immediate medical attention if you experience severe headache, blurred vision, chest pain, or difficulty breathing.
Seizures (Rare (<0.1%))
Call emergency services if you witness a seizure. Do not attempt to restrain the person.
Thromboembolic events (e.g., deep vein thrombosis, pulmonary embolism, stroke, myocardial infarction) (Uncommon (0.1-1%))
Seek immediate medical attention if you notice swelling, pain, or redness in a limb, sudden shortness of breath, chest pain, or neurological symptoms.
Pure red cell aplasia (Rare (<0.01%))
If you experience sudden severe fatigue, paleness, or a drop in haemoglobin despite ongoing treatment, contact your doctor immediately.
Severe allergic reaction (anaphylaxis) (Rare (<0.1%))
Seek emergency medical help if you develop rash, itching, swelling of the face, lips, tongue, or throat, or difficulty breathing.

⚠️ Rare Side Effects

Porphyria exacerbation
Inform your doctor if you have a history of porphyria. Seek medical attention if you develop abdominal pain, neurological symptoms, or skin blisters.
Antibody-mediated pure red cell aplasia
Report to your doctor if you experience a sudden loss of efficacy, severe anaemia, or need for transfusions.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
ACE inhibitors Major
ARBs Major
Warfarin Major
Heparin Major
Cyclosporine Major
Iron supplements Moderate
Androgens Moderate
Desmopressin Moderate

🚨 Major Interactions

  • Angiotensin-converting enzyme (ACE) inhibitors
  • Angiotensin II receptor blockers (ARBs)
  • Anticoagulants (e.g., warfarin, heparin)
  • Cyclosporine

⚡ Moderate Interactions

  • Iron supplements
  • Androgens
  • Desmopressin

🍷 Alcohol Interaction

Alcohol should be avoided while receiving this medicine. Alcohol can increase blood pressure and may worsen the cardiovascular risks associated with this medicine. It can also increase the risk of seizures and liver problems. If you consume alcohol regularly, discuss this with your doctor.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Uncontrolled hypertension","Known hypersensitivity to recombinant human erythropoietin alfa or any excipient","Pure red cell aplasia","Use in patients with anaemia due to iron, folate, or vitamin B12 deficiency without correction","Use in patients with cancer receiving chemotherapy with curative intent (in some regions)","Use in patients undergoing cardiac or vascular surgery with expected severe blood loss (in some regions)"]

⚠️ Warnings & Precautions

["This medicine can cause or worsen hypertension. Monitor blood pressure closely and treat hypertension promptly.","It may increase the risk of seizures, especially in patients with chronic kidney disease.","Thromboembolic events have been reported. Use with caution in patients with a history of thrombosis.","In cancer patients, targeting haemoglobin levels above 12 g/dL may increase the risk of tumour progression and mortality.","Pure red cell aplasia may occur due to neutralizing antibodies. If suspected, stop the medicine and investigate.","Ensure adequate iron stores before and during therapy; iron deficiency reduces efficacy.","Do not use in patients with uncontrolled hypertension or known hypersensitivity.","Use with caution in patients with liver disease, sickle cell disease, or porphyria.","The safety and efficacy in paediatric patients have not been established for all indications.","Do not shake the vial; avoid vigorous agitation."]

🤱 Lactation Safety

It is not known whether recombinant human erythropoietin alfa is excreted in human breast milk. Because many medicines are excreted in breast milk, caution should be exercised when this medicine is administered to a nursing woman. Consult your doctor before breastfeeding.

💊 Overdose Management

Overdose of this medicine can lead to excessive erythropoiesis, resulting in polycythaemia, hypertension, and thromboembolic events. There is no specific antidote. Treatment is supportive and symptomatic. If overdose is suspected, stop the medicine and monitor haemoglobin, haematocrit, and blood pressure closely. Phlebotomy may be considered in severe cases. Contact a poison control centre or emergency department immediately.

⏰ Missed Dose

If you miss a dose of this medicine, contact your doctor or nurse for guidance. Do not take a double dose to make up for a missed one. The dosing schedule for this medicine is usually determined by your healthcare provider, and they will advise you on what to do if a dose is missed.

Additional Safety Advice

General Safety

This medicine must only be administered under medical supervision. Do not self-inject unless you have been trained and instructed by your healthcare provider. Your doctor will monitor your blood pressure, haemoglobin levels, and iron stores regularly. Keep all appointments for blood tests. Do not increase or decrease the dose without consulting your doctor. Inform your doctor if you have a history of high blood pressure, seizures, blood clots, heart disease, or cancer. Tell your doctor about all other medicines you are taking, especially those that affect blood pressure or blood clotting. Avoid alcohol while on this medicine as it may worsen hypertension. If you miss a dose, contact your doctor for guidance; do not double the dose. Store this medicine in the refrigerator at 2°C to 8°C; do not freeze. Keep it away from direct light. Do not use if the solution is discoloured or contains particles. Report any signs of allergic reaction, severe headache, chest pain, or difficulty breathing immediately.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients may be more susceptible to hypertension and cardiovascular events. Blood pressure should be monitored closely, and the dose should be individualized. Falls risk may be increased if dizziness occurs.

🤰 Pregnancy Planning (TTC)

If you are planning to become pregnant, discuss with your doctor. This medicine should be used during pregnancy only if clearly needed. Effective contraception may be advised while on this medicine, depending on your condition.

🏥 Post-Surgery Considerations

After surgery, this medicine may be continued or adjusted based on your haemoglobin levels and overall condition. Monitor for signs of thromboembolism, especially if you are immobile. Follow your surgeon's instructions for activity and blood clot prevention.

🦷 Dental Procedures

Inform your dentist that you are receiving this medicine. There is no specific contraindication for dental procedures, but if you have a bleeding disorder or are on anticoagulants, your dentist may take extra precautions.

💚 Lifestyle Tips for Better Results

🏃
Maintain a healthy blood pressure through diet, exercise, and medication as prescribed.
🥗
Eat a balanced diet rich in iron, vitamin B12, and folate to support red blood cell production.
😴
Stay hydrated unless your doctor has restricted fluids.
💧
Avoid smoking and limit alcohol consumption.
🧘
Engage in regular light exercise as tolerated to improve cardiovascular health.
🌞
Get adequate rest and manage stress.
🚭
Keep all appointments for blood tests and check-ups.

🏋️ Exercise Considerations

Moderate exercise is generally safe, but avoid strenuous activity if you have severe anaemia or cardiovascular disease. Consult your doctor before starting any exercise programme. If you experience dizziness, chest pain, or shortness of breath during exercise, stop and seek medical attention.

🥗 Diet Recommendations

Include iron-rich foods such as lean red meat, poultry, fish, beans, and fortified cereals.
Consume vitamin C-rich foods to enhance iron absorption.
Ensure adequate intake of vitamin B12 and folate.
Limit high-potassium foods if you have kidney disease.
Reduce sodium intake to help control blood pressure.
Avoid alcohol.

💼 Impact on Daily Work & Life

This medicine may cause dizziness or fatigue in some patients. If you experience these, avoid driving or operating heavy machinery until you know how the medicine affects you. Most patients can continue their normal activities, but listen to your body and rest when needed.

🛑 When to Stop This Medicine

Do not stop this medicine without consulting your doctor. It is usually continued as long as needed to maintain target haemoglobin levels. If you experience serious side effects or if the medicine is not effective, your doctor may decide to stop it. In cancer patients, it may be stopped after chemotherapy is completed.

📅 Long-Term Use Effects

Long-term use of this medicine may increase the risk of cardiovascular events, hypertension, and thromboembolism. Regular monitoring of haemoglobin, blood pressure, and iron status is essential. In cancer patients, targeting higher haemoglobin levels may increase the risk of tumour progression. Pure red cell aplasia is a rare but serious long-term complication. The medicine should be used at the lowest effective dose and discontinued if no benefit is observed.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Iron supplementation

Correcting iron deficiency can improve anaemia and may reduce the need for this medicine.

Evidence: Well-established
Blood transfusion

Used for severe anaemia or when this medicine is ineffective or contraindicated.

Evidence: Well-established
Darbepoetin alfa

A longer-acting erythropoiesis-stimulating agent that requires less frequent dosing.

Evidence: Well-established

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

There are no specific vaccine interactions reported with this medicine. However, patients with chronic kidney disease or cancer may have weakened immune responses. Consult your doctor about appropriate vaccinations, including influenza and pneumococcal vaccines.

📦 Storage Guide

✅ DO

Store in the refrigerator at 2°C to 8°C

❌ DON'T

Do not freeze

✅ DO

Keep the vial in the original carton to protect from light

❌ DON'T

Do not expose to direct sunlight

✅ DO

Do not shake the vial

❌ DON'T

Do not use if the solution is discoloured or contains particles

✅ DO

Keep out of reach of children

❌ DON'T

Do not store at room temperature for extended periods

✈️ Traveling with This Medicine

When travelling with this medicine, carry it in its original packaging with the prescription label. Keep it in a cool bag or refrigerator if available; if not, use a cooler pack to maintain temperature between 2°C and 8°C. Carry a copy of your prescription and a doctor&#039;s letter explaining the medical need. Check airline regulations for carrying injectable medicines and sharps. If crossing time zones, consult your doctor about adjusting the dosing schedule. Do not expose the medicine to extreme temperatures or direct sunlight.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 58-year-old man with chronic kidney disease on dialysis
He had been feeling constantly tired and short of breath. His doctor prescribed this medicine three times a week after dialysis. After about six weeks, his haemoglobin improved, and he noticed he could walk longer distances without getting breathless. He learned to monitor his blood pressure at home and report any headaches.
💡 Lesson: Regular monitoring and adherence to the prescribed schedule are key to improving anaemia symptoms and quality of life.
👤 A 45-year-old woman undergoing chemotherapy for breast cancer
She developed anaemia during chemotherapy and needed frequent blood transfusions. Her oncologist started this medicine once weekly. Her haemoglobin stabilized, and she required fewer transfusions. She was advised to take iron supplements and to report any leg swelling or chest pain immediately.
💡 Lesson: This medicine can reduce transfusion needs in chemotherapy patients, but close monitoring for thromboembolic events is essential.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: This medicine usually starts to increase reticulocyte count within 3 to 7 days, but a noticeable rise in haemoglobin may take 2 to 6 weeks. Your doctor will monitor your levels and adjust the dose accordingly.

Q: Can I self-administer this injection?

A: Only if your doctor has trained you to do so. Otherwise, it should be given by a healthcare professional.

Q: What are the most important side effects to watch for?

A: Watch for high blood pressure, severe headache, chest pain, shortness of breath, swelling in legs, or signs of allergic reaction. Report these to your doctor immediately.

Q: Is this medicine safe during pregnancy?

A: It should be used during pregnancy only if clearly needed. Consult your doctor to weigh the benefits and risks.

Q: Can I travel with this medicine?

A: Yes, but carry it in original packaging with a prescription and maintain the cold chain. Check airline regulations for injectables.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine long-term?
  • Will it affect my kidney function?
  • Can I drive after taking this medicine?
  • Does it interact with my blood pressure medicine?
  • What if I miss a dose?
  • Can I drink alcohol while taking this?
  • Is it safe during pregnancy?
  • How should I store this medicine?

🔄 Substitutes for repoitin 5000 injection

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: This medicine can be used to treat all types of anaemia.
    Fact: This medicine is only effective for anaemia caused by erythropoietin deficiency, such as in chronic kidney disease or chemotherapy. It is not effective for anaemia due to iron, vitamin B12, or folate deficiency unless those deficiencies are corrected.
  • Myth: This medicine is a blood transfusion substitute.
    Fact: This medicine stimulates the body to produce its own red blood cells, but it takes weeks to work. It is not a substitute for emergency blood transfusion in severe anaemia.
  • Myth: More of this medicine will make you feel better faster.
    Fact: Higher doses can increase the risk of serious cardiovascular events and thromboembolism. The dose must be carefully adjusted to maintain haemoglobin within a target range.

🔄 Alternative Options

Generic Alternatives

  • Recombinant human erythropoietin alfa

Brand Alternatives

  • Epofit 5000 IU Injection

📊 Comparison with Similar Medicines

[{"medicine":"Recombinant human erythropoietin alfa","onset":"Gradual (weeks)","half_life":"4-13 hours (IV), ~24 hours (SC)","route":"IV or SC"},{"medicine":"Darbepoetin alfa","onset":"Gradual (weeks)","half_life":"~21 hours (IV), ~49 hours (SC)","route":"IV or SC"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory